Literature DB >> 16724544

In vitro release performance and analgesic activity of endomorphin-1 loaded nanoparticles.

Hui Liu1, Jingman Ni, Rui Wang.   

Abstract

Endomorphin-1 normally has a short half-live in blood and brain and has difficulty in penetrating the blood-brain barrier when given intravenously. To transport endomorphin-1 across the blood-brain barrier, the peptide was adsorbed onto the surface of butylcyanoacrylate nanoparticles and coated with polysorbate 80. The release properties of the drug in vitro were demonstrated. The central analgesic effect of the drug was measured by tail flick test. The results of the in vitro release study show that there is a burst release effect at first and a slow and continuous release then followed. A longer analgesic effect was shown when the nanoparticles coated with polysorbate 80 were intravenously injected into mice than with the other groups including endomorphin-1, nanoparticles uncoated with polysorbate 80, and a simple mixture of the three components (drug, nanoparticles, and surfactant) mixed directly. The results showed that the way we used to promote endomorphin-1 penetration of the blood-brain barrier was useful. These results suggested that nanoparticles coated with polysorbate 80 were useful for delivery of EM-1 loaded nanoparticles to target the brain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16724544

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  3 in total

Review 1.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

Review 2.  Engineering endomorphin drugs: state of the art.

Authors:  Lawrence H Lazarus; Yoshio Okada
Journal:  Expert Opin Ther Pat       Date:  2012-01-04       Impact factor: 6.674

Review 3.  The use of lipid-based nanocarriers for targeted pain therapies.

Authors:  Susan Hua; Sherry Y Wu
Journal:  Front Pharmacol       Date:  2013-11-21       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.